(1) systematically analyzed m6A methylation levels in 33 types of cancer patients and found that the m6A methylation regulator has a wide range of gene mutations, and identified an m6A methylation regulator closely associated with a variety of cancers: IGF2BP3. Here, IGF2BP3 is linked to cancer.